Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Curis, Inc.

http://www.curis.com

Latest From Curis, Inc.

Coronavirus Notebook: Hearings On Pandemic Treaty Begin, New Risk-Sharing Partnership To Boost COVAX Efforts

Médecins Sans Frontières says the latest draft of the proposed IP waiver must be rejected, and the WHO has suspended supply of Bharat’s COVID-19 vaccine over manufacturing issues. Two EU agencies have issued advice on fourth doses of mRNA vaccines, while GlaxoSmithKline has filed high-dose sotrovimab for patients with suspected Omicron BA.2 infection in Australia.

Coronavirus COVID-19 Vaccines

Biological E's COVID-19 Vaccine Launched, MD Says India Supplies To WHO Not Under Threat

Despite Indian companies not being able to honor COVID-19 vaccine export commitments, Biological E’s MD believes mitigating circumstances mean relations with the agency won’t be damaged. Meanwhile, Corbevax is being used in India's immunization program and a tech transfer for Johnson & Johnson’s COVID-19 vaccine is going ahead.

Commercial Business Strategies

Bill Gates Backs mRNA Capacity In India, Pitches Cutting Gene Therapy Cost

Billionaire philanthropist and co-chair of the Bill and Melinda Gates Foundation signals efforts underway to support building mRNA capacity in India amid the new platform’s potential beyond COVID-19 vaccines. He also highlights the need to bring down sharply the cost of gene therapies.

Research & Development Coronavirus COVID-19

Coronavirus Update: Japan Paxlovid Approval, US Lifts Covaxin IND Hold

Japan has added to its growing arsenal of COVID-19 treatments with the approval of the oral antiviral Paxlovid, while the US FDA has lifted a clinical hold on Bharat's vaccine, which has shown potential against Omicron. Also, Biological E's vaccine is approved for use in adolescents in India

Japan Coronavirus COVID-19
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register